Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study

BACKGROUND: The purpose of this study was to compare the efficacy and safety of utidelone plus capecitabine for advanced first-line versus second-line or above therapy in metastatic breast cancer patients who had previously received anthracycline and taxane. At the same time, we compared the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Pingping, Wang, Xi, Liu, Rui, Li, Xiuqin, Wei, Shanrong, Zhao, Jiawen, Tan, Xin, Zhang, Fan, Mao, Qing, Zhang, Ying, Tang, Baoyan, Xun, Xueqiong, Guo, Rong, Zheng, Kai, Zhou, Shaoqiang, Tang, Shicong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665706/
https://www.ncbi.nlm.nih.gov/pubmed/38026829
http://dx.doi.org/10.1016/j.sopen.2023.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665706/
https://www.ncbi.nlm.nih.gov/pubmed/38026829
http://dx.doi.org/10.1016/j.sopen.2023.10.008

Ejemplares similares